Literature DB >> 16219363

Immune responses after local administration of IgY loaded-PLGA microspheres in gut-associated lymphoid tissue in pigs.

Anne-Marie Torché1, Mireille Le Dimna, Pascal Le Corre, Alain Mesplède, Sébastien Le Gal, Roland Cariolet, Marie-Frédérique Le Potier.   

Abstract

Oral vaccination of large animals using PLGA MS (poly(D,L-lactide-co-glycolide)microspheres) appeared to be more challenging than immunization of mice. The purpose of this study was to deliver to GALT an immunogenic model protein (IgY), free or encapsulated by spray-drying in PLGA MS, and to evaluate systemic immune response in SPF Large White pigs. Pigs were surgically processed for local administration of IgY in three sets of experiments. In two sets of experiments, administration was locally performed in temporary ligatured intestinal segments, in jejunal Peyer's patches and in mesenteric lymph nodes. In the third experiment, pigs received IgY via an intestinal cannula. Total IgY-specific antibodies were detected in the sera of pigs after a single local immunization, but not in the sera of cannulated pigs. The study of IgG1 and IgG2 isotypes indicated that PLGA MS are able to elicit a combined serum IgG2/G1 response with a predominance of IgG1 response when locally administered. PLGA MS can be a potential oral delivery system for antigen but our results underlined the difficulty to immunize large animals like pigs. Transposition of data between small and large animals appears to be complex and suggests that physiological features need to be considered to increase intestinal availability of oral encapsulated vaccines.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16219363     DOI: 10.1016/j.vetimm.2005.08.016

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  13 in total

1.  pH-responsive hydrogels to protect IgY from gastric conditions: in vitro evaluation.

Authors:  R V Bellingeri; N Y Picco; F E Alustiza; J V Canova; M A Molina; D F Acevedo; C Barbero; A B Vivas
Journal:  J Food Sci Technol       Date:  2014-04-10       Impact factor: 2.701

2.  Recombinant monovalent llama-derived antibody fragments (VHH) to rotavirus VP6 protect neonatal gnotobiotic piglets against human rotavirus-induced diarrhea.

Authors:  Celina G Vega; Marina Bok; Anastasia N Vlasova; Kuldeep S Chattha; Silvia Gómez-Sebastián; Carmen Nuñez; Carmen Alvarado; Rodrigo Lasa; José M Escribano; Lorena L Garaicoechea; Fernando Fernandez; Karin Bok; Andrés Wigdorovitz; Linda J Saif; Viviana Parreño
Journal:  PLoS Pathog       Date:  2013-05-02       Impact factor: 6.823

3.  Dengue virus specific IgY provides protection following lethal dengue virus challenge and is neutralizing in the absence of inducing antibody dependent enhancement.

Authors:  Ashley L Fink; Katherine L Williams; Eva Harris; Travis D Alvine; Thomas Henderson; James Schiltz; Matthew L Nilles; David S Bradley
Journal:  PLoS Negl Trop Dis       Date:  2017-07-07

Review 4.  IgY antibodies for the immunoprophylaxis and therapy of respiratory infections.

Authors:  Aymn Talat Abbas; Sherif Aly El-Kafrawy; Sayed Sartaj Sohrab; Esam Ibraheem Ahmed Azhar
Journal:  Hum Vaccin Immunother       Date:  2018-09-19       Impact factor: 3.452

5.  Zika Virus-Specific IgY Results Are Therapeutic Following a Lethal Zika Virus Challenge without Inducing Antibody-Dependent Enhancement.

Authors:  Kyle L O'Donnell; Bernadette Meberg; James Schiltz; Matthew L Nilles; David S Bradley
Journal:  Viruses       Date:  2019-03-26       Impact factor: 5.048

Review 6.  Avian IgY antibodies and their recombinant equivalents in research, diagnostics and therapy.

Authors:  Edzard Spillner; Ingke Braren; Kerstin Greunke; Henning Seismann; Simon Blank; Dion du Plessis
Journal:  Biologicals       Date:  2012-06-28       Impact factor: 1.856

7.  IgY antibodies protect against human Rotavirus induced diarrhea in the neonatal gnotobiotic piglet disease model.

Authors:  Celina G Vega; Marina Bok; Anastasia N Vlasova; Kuldeep S Chattha; Fernando M Fernández; Andrés Wigdorovitz; Viviana G Parreño; Linda J Saif
Journal:  PLoS One       Date:  2012-08-03       Impact factor: 3.240

Review 8.  IgY - turning the page toward passive immunization in COVID-19 infection (Review).

Authors:  Carolina Constantin; Monica Neagu; Teodora Diana Supeanu; Viorica Chiurciu; Demetrios A Spandidos
Journal:  Exp Ther Med       Date:  2020-04-30       Impact factor: 2.447

Review 9.  Targeting the porcine immune system--particulate vaccines in the 21st century.

Authors:  Kenneth C McCullough; Artur Summerfield
Journal:  Dev Comp Immunol       Date:  2008-09-02       Impact factor: 3.636

Review 10.  Immunoglobulin Y for Potential Diagnostic and Therapeutic Applications in Infectious Diseases.

Authors:  Lucia Lee; Kate Samardzic; Michael Wallach; Lyn R Frumkin; Daria Mochly-Rosen
Journal:  Front Immunol       Date:  2021-06-09       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.